|

Paclitaxcel Q3W Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • University of California, Irvine1

Indications

  • Hepatobiliary Carcinoma in Situ1
  • Gastric Cancer (Diagnosis)1
  • Appendiceal Adenocarcinoma1
  • Small Bowel Adenocarcinoma1
  • Esophageal Carcinoma1

Orange, California1 trial

Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)

Chao Family Comprehensive Cancer Center, University of California, Irvine

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.